Bin Tean Teh

27PUBLICATIONS
142CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisInnate immunityEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Apr 01, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers.

Jing Han Hong, Chern Han Yong, Hong Lee Heng

|Feb 04, 2026
ZNF395 Is a Hypoxia-Responsive Regulator of Mitochondrial Glutaminolysis in Clear Cell Renal Cell Carcinoma.

Joanna Koh, Chengheng Liao, Michelle Shu Wen Ng

|Oct 15, 2025
Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma.

Cheng Huang, Yan Gao, Jianfeng Chen

|Jan 03, 2025
Effects of RARα ligand binding domain mutations on breast fibroepithelial tumor function and signaling.

Xi Xiao Huang, Ley Moy Ng, Po-Hsien Lee

|Aug 09, 2024
Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability.

Peiyong Guan, Jianfeng Chen, Chengqiang Mo

|May 23, 2024
Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expression.

Yichen Sun, Jianfeng Chen, Jing Han Hong

Pageof 5

Frequent Collaborators

8 joint publications

Jing Han Hong

8 joint publications

Jason Yongsheng Chan

6 joint publications

Peiyong Guan

6 joint publications

Cedric Chuan-Young Ng